# Radboud University Medical Center: Observational study completed, 915 enrolled (Overweight , Obesity, Obesity (Disorder))

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | Radboud University Medical Center |
| Sponsor type | Academic and hospital |
| Study | Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity |
| NCT ID | NCT07504172 |
| Phase | Observational |
| Status | completed |
| Conditions | Overweight , Obesity; Obesity (Disorder) |
| Intervention types | drug |
| Target enrollment | 915 |
| Site countries | Netherlands |
| Posted | 2026-03-31 |
| Planned start | 2026-04-01 |
| Event | Completed |
| Event date | 2026-10-14 |
| Last update posted | 2026-10-28 |

## Why this score
- Posted in the last two weeks.
- Completed: closeout, analysis and the next study ahead.
- 915 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07504172). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.